glp-1 patent expiration India Obesity Crisis: The Expiry of Ozempic's in 2026 Could Revolutionize India's Battle Against Obesity, ETPharma Generic GLP-1 Medications Expected on

This may require months of careful management

Better Metabolic Flexibility and Mitochondrial Health Metabolic flexibilitythe ability to switch between burning carbohydrates and fatsis impaired in obesity and insulin resistance

The weight loss is considered a welcome side effect of a covered treatment

Sometimes we see patients say, OK, Im just going to take this medication, or Im just going to do this surgery, and I really dont have to change what Im doing, and they tend to be much less successful. People with obesity or who are overweight still have success losing weight on Zepbound, the brand name version of tirzepatide, regardless of other obesity-related conditions like hypertension

Your genes influence how you respond to GLP-1 therapy

For this reason, I generally recommend against the regular use of SSRIs in obese patients and instead would recommend a trial of Wellbutrin instead